Forbes Sustainability Leaders 2025: Nominations Are Open
In the U.S., landmark environmental policies are being reversed even as climate-fueled disasters intensify and cost the economy billions. Globally, companies that once led on net-zero are walking back their ambitions, revising timelines, softening disclosures, and retreating from public pledges. New reporting requirements are being introduced and immediately challenged in legislatures and boardrooms. Capital is flowing into climate solutions at record levels, but it's not always aligned with need, particularly in the Global South. Disinformation about sustainability is rising just as fast as public concern over the environment. And while AI promises breakthroughs, it's also accelerating demand for energy and infrastructure. We know what must be done, but putting solutions into practice seems more difficult than ever.
Even so, progress is being made by those willing to keep building. In its second year, the Forbes Sustainability Leaders list will spotlight people turning ambition into scalable action, building solutions in an economic and political climate of uncertainty. In this moment, we're looking to honor leaders with clarity of purpose and the resolve to act when conditions are far from perfect.
Forbes
Last year's honorees reflected the full breadth of what climate leadership looks like today: entrepreneurs reimagining how industries operate, artists reshaping culture, and scientists reporting from the front lines. Among them were Indigenous activist Nemonte Nenquimo, whose legal and community-led efforts helped protect vast tracts of Ecuador's Amazon rainforest; Joy Belmonte, mayor of Quezon City, who advanced one of Southeast Asia's most ambitious urban climate agendas; Peter Kalmus, a NASA climate scientist whose advocacy bridges research and public communication; RJ Scaringe, founder and CEO of electric vehicle company Rivian; and Catherine Coleman Flowers, whose environmental justice work confronts sanitation inequality in underserved U.S. cities.
Their work was evaluated by a global panel of judges spanning science, finance, advocacy, and policy—including Laurene Powell Jobs, founder of Emerson Collective and the Waverley Street Foundation; Bill McKibben, author and founder of the global climate networks 350.org and Third Act; and Nnimmo Bassey, Nigerian poet, environmentalist, and longtime advocate for ecological justice and Indigenous rights.
Forbes
This September, the list will return—launching in concert with the Forbes Sustainability Leaders Summit during New York Climate Week.
We're seeking nominations from founders, policymakers, investors, organizers, artists, scientists, and others driving impact around the world. Whether you're building technology, restoring ecosystems, financing adaptation, or rethinking entrenched systems—we want to hear from you. See the guidelines below, and read more about our methodology here.
The deadline to submit all nominations for the list is 9:00am ET on Friday, June 13, 2025.
Some honorees may be widely recognized names; others may be rising leaders doing critical work behind the scenes. What unites them is not status or tenure, but forward motion—they are not being honored for legacy, but for current contributions. We're looking for individuals who are driving impact now: ambitious, inventive, and actively shaping the future. As we evaluate candidates for this year's Forbes Sustainability Leaders list, we're considering the following:
Our cohort's work is authentic and delivers proven, discernible positive impacts—no greenwashed efforts.
Nominees are proactive, not passive. They stand up, engage in dialogue, lead teams, and pave new paths forward. They are risk-takers.
Our leaders focus on exploring new frontiers, challenging existing limits, and solving problems in unique ways. They are pioneers in their field.
We look for visionaries who not only have smart solutions but also possess viable plans and the drive to scale their impact.
We prioritize candidates who have made significant contributions to environmental sustainability in the last few years.
Our nominees strive to create solutions that benefit everyone, recognizing that sustainability is inseparable from social justice.
The process to create the annual list begins with an open call for nominations. There is no application fee. Candidates are initially reviewed by Forbes staff, and finalists may be asked to provide additional information. The selection is further refined by panels of industry experts, and Forbes editors ultimately compile the most compelling candidates into the final Forbes Sustainability Leaders List, which will be presented alphabetically, not ranked.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Rivian reports mixed Q2 results, widens 2025 loss projection as tariffs & loss of EV tax credit bite
Rivian (RIVN) reported mixed second quarter earnings after the bell on Tuesday, and did not report a gross profit as policy changes like tariffs blunted its performance. The company also widened its full-year loss projection as trade wars and the loss of EV tax credits blunt Rivian's path towards profitability. Rivian said recent policy actions are expected to "continue to have an impact on its results and cash flows of its business," and because of some of the recent changes associated with regulatory credits and its second quarter performance, the company is increasing its adjusted 2025 full-year EBITDA (earnings before interest, taxes, depreciation, and amortization) before interest loss range to $2.0 billion to $2.25 billion, from $1.7 billion to $1.9 billion previously. Recent policy changes include the Trump administration phasing out the EV tax credit, set to expire on September 30, as well as sector tariffs of 25% on autos and auto parts. Rivian stock was lower in after-hours trading. For the quarter, Rivian reported revenue of $1.303 billion vs $1.28 billion per Bloomberg consensus estimates, higher than the $1.158 billion reported a year ago. The company posted an EPS loss of $0.97 vs $0.77, with an adjusted EBITDA loss of $667 million vs. $493 million expected. Rivian also did not post gross profit for the quarter, which it had done the last two prior quarters. On the positive front, Rivian said development of its upcoming R2 midsize SUV is progressing. 'This quarter we made significant progress in R2 development and testing. We also substantially completed the expansion of our Normal, Illinois facility and have begun installing manufacturing equipment in preparation for our start of production," CEO RJ Scaringe said in a statement. Rivian said it expects to commission the new R2 line in the third quarter of this year and start validating the equipment and production processes. The R2 is slated for production in 2026. The company said in early July that it produced 5,979 vehicles at its factory in Normal, Ill., and delivered 10,661 vehicles during the second quarter, slightly below analysts' consensus of 10,800. Production was limited during the quarter in preparation for model year 2026 vehicles, expected to launch later this month, the company said. Read more: Live coverage of corporate earnings Rivian reaffirmed its 2025 delivery guidance range of 40,000 to 46,000 vehicles, but it will shut down its factory for three weeks in September for R2 preparations, and in order to increase manufacturing capacity to 215,000 units. "On the call, we'll be looking for further detail on Rivian's progress with its Volkswagen Joint Venture (total deal size of ~$5.8B), and on the company's progress towards autonomy, and towards commercializing its R2 line, which is slated for SOP [start of production] in 1H26," Cantor Fitzgerald analyst Andres Sheppard wrote. Deutsche Bank's Edison Yu added that R2 prototypes have been seen in the wild, further suggesting that 2026 production is in the cards, but there are still headwinds for the business overall. "Heading into 2H, we worry that EV policy headwinds could keep a lid on the stock," he wrote in late July. "Moreover, the company is expected to experience some downtime related to R2, hurting overhead absorption." Pras Subramanian is the lead auto reporter for Yahoo Finance. You can follow him on X and on Instagram. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Lucid cuts annual production forecast as global trade tensions sting
(Reuters) - Lucid lowered its annual production forecast and missed Wall Street estimates for quarterly revenue on Tuesday, at a time when U.S. trade tensions have cast a dark cloud over some automakers as consumers rein in big spending budgets. Shares of the company dropped over 10% in extended trading. Despite seeing a rise in deliveries for its luxury electric vehicles, Lucid is navigating an uncertain time for the industry as U.S. import tariffs threaten to upend supply chains and raise the costs of vehicles by thousands of dollars. The company has been aggressively striking deals with North American companies in order to domestically source critical minerals used in EV manufacturing amid a push by the Trump administration to reshore production and strengthen American manufacturing. Lucid's fortunes rely heavily on the success of its newly launched Gravity SUV and the upcoming mid-size car, which targets a $50,000 price point, as the company looks to expand its consumer base. Competition in the U.S. EV market is also stiff, with industry giant Tesla pushing sales of its revamped Model Y, and Rivian marketing its refreshed versions of the R1T truck and R1S SUV. Lucid now expects to make between 18,000 and 20,000 vehicles this year, compared to its previous forecast of 20,000 vehicles. In order to diversify revenue streams, Lucid signed a deal with Uber last month, whereby over six years, starting in 2026, the ride-hailing platform will acquire and deploy over 20,000 Lucid Gravity SUVs that will be equipped with autonomous vehicle technology from startup Nuro. As part of the deal, Uber will invest $300 million in Lucid as the firms look to establish a foothold in the robotaxi market. Lucid reported revenue of $259.4 million in the second quarter, missing estimates of $279.9 million, according to data compiled by LSEG. On an adjusted basis, the company lost 24 cents per share, compared with estimates of a loss of 21 cents per share.
Yahoo
20 minutes ago
- Yahoo
Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones. Companies had a lower bar to clear coming into the quarter, as analysts tempered their expectations amid President Trump's tariffs, stocks' lofty valuations, and uncertainty about the health of the US economy. This week, investors will hear from Tyson (TSN), AMD (AMD), Snap (SNAP), McDonald's (MCD), Disney (DIS), Uber (UBER), Lyft (LYFT), Palantir (PLTR), and more when they report results. Data from FactSet published Friday showed that with 66% of the index having reported results, analysts expect S&P 500 companies to report a 10.3% jump in earnings per share during the second quarter. Heading into the quarter, analysts expected S&P 500 earnings to rise 5% in Q2, which would mark the slowest pace of earnings growth since the fourth quarter of 2023. Here are the latest updates from corporate America. Rivian Q2 earnings preview: EV tax credit impact, R2 SUV update on the agenda Pure-play EV maker Rivian (RIVN) has been building toward profitability, but the loss of federal EV tax credits expiring at the end of September will likely hurt the company's ability to scale up sales. Yahoo Finance's Pras Subramanian previews what to expect when Rivian reports second quarter earnings after the bell on Tuesday: Read more here. Yum Brands stock falls amid underperformance in the US Yum Brands (YUM) stock fell over 3% on Tuesday after an earnings miss and weaker-than-expected sales in the US amid a tougher consumer environment. "Even with a solid overall top line performance, we have opportunities to improve performance in underperforming regions such as the US and parts of Europe, where challenges stem from gaps in value perception, inconsistent consumer experience, and innovation that has not fully resonated with consumers," Yum Brands CEO David Gibbs said on the earnings call. The Taco Bell parent company reported earnings per share of $1.44 adjusted versus $1.46 expected, according to estimates compiled by S&P Global Market Intelligence. Revenue for the quarter hit $1.93 billion, roughly in line with the $1.94 billion expected. US same-store sales for KFC and Pizza Hut fell 5% year over year. US system sales for Taco Bell grew 6%. Lemonade stock jumps on solid guidance Lemonade (LMND) stock jumped 8% in premarket trading as the insurance company kicked off its earnings call and reported a narrower loss than expected. In the second quarter, Lemonade posted a loss of $0.60 per share. Analysts were expecting an $0.80 per share loss. Revenue of $164.1 million beat estimates for $160.8 million and rose 34% from the same period a year ago. Gross profit increased by 109% year on year to $64.3 million, while gross margin improved by 14 points to 39%, the company said. Lemonade also raised its full-year revenue guidance to $710 million-$715 million. Listen to the earnings call here. Caterpillar warns of up to $1.5 billion tariff hit, profit misses on weak demand Caterpillar (CAT) is expecting a bigger hit from tariffs in the third quarter and the rest of 2025 than it initially projected, as President Trump's tariffs hit the industrial and manufacturing segment especially hard. The company flagged a tariff impact of $400 million to $500 million in the third quarter and $1.5 billion hit from costs tied to US tariffs in 2025. Caterpillar was able to offset some of the higher tariff costs; however, higher interest rates and a slowdown in US construction activity led to a pullback in demand for its products. The heavy machinery manufacturer reported adjusted earnings per share of $4.72 on revenue of $16.6 billion. Analysts were expecting adjusted EPS of $4.90 on revenue of $16.3 billion, according to S&P Global Market Intelligence. Caterpillar stock fell less than 1% in premarket trading. Marriott cuts 2025 revenue forecast on soft travel demand Marriott (MAR) signaled it's seeing a slowdown in travel demand amid economic pressures, but more affluent consumers remain more resilient. The hotel chain's adjusted diluted EPS totaled $2.65, compared to estimates of $2.61, according to S&P Global Market Intelligence consensus estimates. Revenue per room increased 1.5% globally during the quarter. For the full year, Marriott forecast room revenue growth of 1.5% to 2.5%, moving its previous higher-end estimate of a 3.5% increase lower. 2025 adjusted profit is expected to be between $9.85 and $10.08 per share, also slightly lower than its earlier projection of $9.82 to $10.19 per share. Reuters reports: Read more here. Pfizer beats Q2 earnings estimates, reaffirms 2025 outlook Pfizer reported an earnings and revenue beat on Tuesday, sending shares higher in premarket trading. For the quarter, Pfizer posted earnings per share of $0.78, versus estimates of $0.58 per share, on revenue of $14.7 billion, compared to Wall Street expectations of $13.5 billion. Yahoo Finance's Anjalee Khemlani reports: Read more here. Mazda forecasts nearly $1 billion profit hit from US tariffs Reuters reports: Read more here. BP vows to do better for investors as profit tops forecast Reuters reports: Read more here. Diageo delivers on annual forecasts, shares jump Reuters reports: Read more here. Dan Ives: Palantir's 'transformational' quarter paves way for $1 trillion market cap Wedbush tech analyst and Palantir (PLTR) bull Dan Ives said he sees the AI software company reaching a trillion-dollar market cap in the next two to three years. "This is transformational, the type of growth they're seeing," Ives said of Palantir's first billion-dollar quarter for revenue, comparing the company to AI-forward Big Tech behemoths like Nvidia (NVDA) and Microsoft (MSFT). "You combine that with what we saw last week from the hyperscalers, that just shows us this AI revolution — it's just started in terms of the next stage of growth," Ives added. Listen to Palantir's earnings call live on the stock page here. Hims & Hers stock tumbles on revenue miss Shares of Hims & Hers (HIMS) slid 11% in after-hours trading following the telehealth company's second quarter results and revenue miss. Earnings came in at $0.17 per share, a slight beat over estimates for $0.16 per share, according to S&P Global Market Intelligence. Second quarter revenue rose 73% year over year, reaching $544.83 million. But it fell short of Wall Street's estimates for $552 million in sales. The company affirmed its full-year guidance of $2.3 billion to $2.4 billion in sales. For the third quarter, it expects $570 million to $590 million in sales. In June, Novo Nordisk (NVO) announced it was terminating an agreement to sell its blockbuster GLP-1 drug Wegovy on the Hims & Hers platform. Investors will be looking to the earnings call for more details on the fallout. Novo Nordisk also cut its sales forecasts for its weight-loss drugs, citing rivals selling compounded versions, such as Hims & Hers. Listen to the earnings call live. Palantir stock surges after company reports first billion-dollar quarter Yahoo Finance's Jake Conley reports: Read more here. Post-earnings stock moves are more volatile than usual this quarter We're two-thirds of the way through earnings season, and for the most part, the market has floated higher on a flurry of earnings releases. Though some individual reports have led to outsized moves. Yahoo Finance's Josh Schafer writes in today's Morning Brief: Read more here. BioNTech shares rise 4% on better-than-expected earnings US-listed shares of the German drugmaker BioNTech (BNTX) rose about 4% in early trading Monday after the company reported better-than-expected second quarter results as it looks to regain momentum after a post-COVID slump. BioNTech reported a loss of 1.60 euros per share, narrower than the 1.69 euro loss analysts expected, according to data from S&P Global Market Intelligence. Revenue of 260.8 million euros ($301 million) fell short of estimates of 263.68 million euros ($304 million). In June, BioNTech announced it would partner with Bristol Myers Squibb (BMY) on a new cancer treatment. "We aim to establish BNT327 both as a new standard of care across multiple tumor types," BioNTech CEO Ugur Sahin said on the company's earnings call. "We are currently advancing BNT327 across more than 10 indications, including two global registrational trials, with more planned. Our early conviction around this modality and BNT327 has put us in a strong position, and if approved, we aim to be the first or second to launch in a number of indications to patients in need." Meatpacker Tyson Foods raises annual revenue forecast on resilient chicken demand Shares of Tyson Foods (TSN) rose 4% in premarket trading on Monday after the company reported fiscal third quarter results and shared that chicken sales are expected to offset beef. Tyson reported adjusted earnings per share of $0.91, and net sales rose 4% to $13.88 billion. Wall Street analysts expected earnings of $0.78 per share on $13.55 billion in revenue. In the third quarter, chicken sales rose 3.5% while volumes increased 2.4%. Volumes in Tyson's beef segment were down 3.1% during the quarter, but sales grew 6.9% as prices jumped 10%. For the fiscal year, Tyson anticipates sales to grow 2% to 3% compared to fiscal 2024 and overall adjusted operating income of $2.1 billion to $2.3 billion. Reuters reports: Read more here. Wayfair stock soars after furniture retailer swings to a profit Wayfair (W) stock shot up 13% in premarket trading on Monday after the online furniture retailer reported its highest revenue growth and profitability since 2021. Wayfair posted diluted earnings of $0.11 per share, above estimates for a loss of $0.37 per share, according to S&P Global Market Intelligence. Revenue rose 5% to $3.27 billion, beating Wall Street's expectations of $3.12 billion. Net revenue in the US rose 5.3% to $2.9 billion in the quarter, while international net revenue increased 3.1% to $399 million. "The second quarter was a resounding success, defined by accelerating sales and share gain, in tandem with expanding profitability," Wayfair CEO Niraj Shah said in a statement. "As we have discussed over the last few years, we can and will grow profitably, while taking significant share in the market." A look at earnings two-thirds of the way through Q2 reporting season The major stock indexes recorded weekly losses on Friday after a full schedule of earnings, new tariff policy for US trading partners, Federal Reserve interest rate decision, and a weaker-than-expected July jobs report. Data from FactSet published Friday showed that we are two-thirds of the way through the second quarter reporting period, with 66% of S&P 500 companies having reported results so far. As of Aug. 1, S&P 500 firms are tracking for 10.3% earnings growth for Q2. If that rate holds, it will mark the third straight quarter of double-digit earnings growth for the index. Investors are still waiting to hear from the remaining third of companies, however. On deck next week are results from AMD (AMD), Snap (SNAP), McDonald's (MCD), Disney (DIS), Uber (UBER), Lyft (LYFT), and more. Here's a look at the earnings calendar for the next five business days: Monday: BioNTech (BNTX), Hims & Hers (HIMS), Palantir (PLTR) Tuesday: AMD (AMD), Amgen (AMGN), BP (BP), Caterpillar (CAT), Duke Energy (DUK), DuPont (DD), Lemonade (LMND), Marathon Petroleum (MPC), Marriott (MAR), Opendoor (OPEN), Pfizer (PFE), Rivian (RIVN), Snap (SNAP), Super Micro Computer (SMCI), Toast (TOST) Wednesday: Airbnb (ABNB), Disney (DIS), DraftKings (DKNG), Dutch Bros (BROS), e.l.f. (ELF), Joby Aviation (JOBY), Lyft (LYFT), McDonald's (MCD), Novavax (NVAX), Occidental Petroleum (OXY), Shopify (SHOP), Sunrun (RUN), Uber (UBER), Zillow Group (Z) Thursday: Atlassian (TEAM), Block (XYZ), Celsius Holdings (CELH), Crocs (CROX), Eli Lilly (LLY), Hertz (HTZ), Instacart (CART), Intuitive Machines (LUNR), Papa John's (PZZA), Peloton (PTON), Pinterest (PINS), Rocket Lab (RKLB), Texas Roadhouse (TXRH), Sweetgreen (SG), Warner Bros. Discovery (WBD), Wynn (WYNN), Yeti (YETI) Friday: Under Armour (UAA), fuboTV (FUBO) Big Tech quarterly results show greater willingness to spend on AI Recent quarterly results from Amazon (AMZN), Alphabet (GOOGL, GOOG), Microsoft (MSFT), and Meta (META) showed Big Tech is still ready to spend hefty sums on artificial intelligence. As the chart below shows, the four tech firms plan to spend $364 billion cumulatively in their fiscal 2025 years. Yahoo Finance's Laura Bratton breaks down Big Tech's AI spending spree: Read more here. Colgate-Palmolive beats quarterly estimates on steady demand for essentials Colgate-Palmolive (CL) stock rose on Friday after the Softsoap maker beat first quarter sales and profit estimates. Despite rising prices and tariffs, consumers continued to purchase essential personal care products, the company said. Colgate reported adjusted profit of $0.92 per share, above analysts' estimates of 90 cents per share, according to data compiled by LSEG. Quarterly net sales reached $5.11 billion, beating estimates of $5.03 billion. Reuters reports: Read more here. Regeneron beats second-quarter results estimates on Dupixent sales boost Regeneron Pharmaceuticals (REGN) stock rose more than 5% before the bell on Friday after beating Wall Street estimates for its second-quarter revenue and profit. The pharmaceuticals company was helped by robust demand for its blockbuster eczema product, Dupixent. Reuters reports: Read more here. Rivian Q2 earnings preview: EV tax credit impact, R2 SUV update on the agenda Pure-play EV maker Rivian (RIVN) has been building toward profitability, but the loss of federal EV tax credits expiring at the end of September will likely hurt the company's ability to scale up sales. Yahoo Finance's Pras Subramanian previews what to expect when Rivian reports second quarter earnings after the bell on Tuesday: Read more here. Pure-play EV maker Rivian (RIVN) has been building toward profitability, but the loss of federal EV tax credits expiring at the end of September will likely hurt the company's ability to scale up sales. Yahoo Finance's Pras Subramanian previews what to expect when Rivian reports second quarter earnings after the bell on Tuesday: Read more here. Yum Brands stock falls amid underperformance in the US Yum Brands (YUM) stock fell over 3% on Tuesday after an earnings miss and weaker-than-expected sales in the US amid a tougher consumer environment. "Even with a solid overall top line performance, we have opportunities to improve performance in underperforming regions such as the US and parts of Europe, where challenges stem from gaps in value perception, inconsistent consumer experience, and innovation that has not fully resonated with consumers," Yum Brands CEO David Gibbs said on the earnings call. The Taco Bell parent company reported earnings per share of $1.44 adjusted versus $1.46 expected, according to estimates compiled by S&P Global Market Intelligence. Revenue for the quarter hit $1.93 billion, roughly in line with the $1.94 billion expected. US same-store sales for KFC and Pizza Hut fell 5% year over year. US system sales for Taco Bell grew 6%. Yum Brands (YUM) stock fell over 3% on Tuesday after an earnings miss and weaker-than-expected sales in the US amid a tougher consumer environment. "Even with a solid overall top line performance, we have opportunities to improve performance in underperforming regions such as the US and parts of Europe, where challenges stem from gaps in value perception, inconsistent consumer experience, and innovation that has not fully resonated with consumers," Yum Brands CEO David Gibbs said on the earnings call. The Taco Bell parent company reported earnings per share of $1.44 adjusted versus $1.46 expected, according to estimates compiled by S&P Global Market Intelligence. Revenue for the quarter hit $1.93 billion, roughly in line with the $1.94 billion expected. US same-store sales for KFC and Pizza Hut fell 5% year over year. US system sales for Taco Bell grew 6%. Lemonade stock jumps on solid guidance Lemonade (LMND) stock jumped 8% in premarket trading as the insurance company kicked off its earnings call and reported a narrower loss than expected. In the second quarter, Lemonade posted a loss of $0.60 per share. Analysts were expecting an $0.80 per share loss. Revenue of $164.1 million beat estimates for $160.8 million and rose 34% from the same period a year ago. Gross profit increased by 109% year on year to $64.3 million, while gross margin improved by 14 points to 39%, the company said. Lemonade also raised its full-year revenue guidance to $710 million-$715 million. Listen to the earnings call here. Lemonade (LMND) stock jumped 8% in premarket trading as the insurance company kicked off its earnings call and reported a narrower loss than expected. In the second quarter, Lemonade posted a loss of $0.60 per share. Analysts were expecting an $0.80 per share loss. Revenue of $164.1 million beat estimates for $160.8 million and rose 34% from the same period a year ago. Gross profit increased by 109% year on year to $64.3 million, while gross margin improved by 14 points to 39%, the company said. Lemonade also raised its full-year revenue guidance to $710 million-$715 million. Listen to the earnings call here. Caterpillar warns of up to $1.5 billion tariff hit, profit misses on weak demand Caterpillar (CAT) is expecting a bigger hit from tariffs in the third quarter and the rest of 2025 than it initially projected, as President Trump's tariffs hit the industrial and manufacturing segment especially hard. The company flagged a tariff impact of $400 million to $500 million in the third quarter and $1.5 billion hit from costs tied to US tariffs in 2025. Caterpillar was able to offset some of the higher tariff costs; however, higher interest rates and a slowdown in US construction activity led to a pullback in demand for its products. The heavy machinery manufacturer reported adjusted earnings per share of $4.72 on revenue of $16.6 billion. Analysts were expecting adjusted EPS of $4.90 on revenue of $16.3 billion, according to S&P Global Market Intelligence. Caterpillar stock fell less than 1% in premarket trading. Caterpillar (CAT) is expecting a bigger hit from tariffs in the third quarter and the rest of 2025 than it initially projected, as President Trump's tariffs hit the industrial and manufacturing segment especially hard. The company flagged a tariff impact of $400 million to $500 million in the third quarter and $1.5 billion hit from costs tied to US tariffs in 2025. Caterpillar was able to offset some of the higher tariff costs; however, higher interest rates and a slowdown in US construction activity led to a pullback in demand for its products. The heavy machinery manufacturer reported adjusted earnings per share of $4.72 on revenue of $16.6 billion. Analysts were expecting adjusted EPS of $4.90 on revenue of $16.3 billion, according to S&P Global Market Intelligence. Caterpillar stock fell less than 1% in premarket trading. Marriott cuts 2025 revenue forecast on soft travel demand Marriott (MAR) signaled it's seeing a slowdown in travel demand amid economic pressures, but more affluent consumers remain more resilient. The hotel chain's adjusted diluted EPS totaled $2.65, compared to estimates of $2.61, according to S&P Global Market Intelligence consensus estimates. Revenue per room increased 1.5% globally during the quarter. For the full year, Marriott forecast room revenue growth of 1.5% to 2.5%, moving its previous higher-end estimate of a 3.5% increase lower. 2025 adjusted profit is expected to be between $9.85 and $10.08 per share, also slightly lower than its earlier projection of $9.82 to $10.19 per share. Reuters reports: Read more here. Marriott (MAR) signaled it's seeing a slowdown in travel demand amid economic pressures, but more affluent consumers remain more resilient. The hotel chain's adjusted diluted EPS totaled $2.65, compared to estimates of $2.61, according to S&P Global Market Intelligence consensus estimates. Revenue per room increased 1.5% globally during the quarter. For the full year, Marriott forecast room revenue growth of 1.5% to 2.5%, moving its previous higher-end estimate of a 3.5% increase lower. 2025 adjusted profit is expected to be between $9.85 and $10.08 per share, also slightly lower than its earlier projection of $9.82 to $10.19 per share. Reuters reports: Read more here. Pfizer beats Q2 earnings estimates, reaffirms 2025 outlook Pfizer reported an earnings and revenue beat on Tuesday, sending shares higher in premarket trading. For the quarter, Pfizer posted earnings per share of $0.78, versus estimates of $0.58 per share, on revenue of $14.7 billion, compared to Wall Street expectations of $13.5 billion. Yahoo Finance's Anjalee Khemlani reports: Read more here. Pfizer reported an earnings and revenue beat on Tuesday, sending shares higher in premarket trading. For the quarter, Pfizer posted earnings per share of $0.78, versus estimates of $0.58 per share, on revenue of $14.7 billion, compared to Wall Street expectations of $13.5 billion. Yahoo Finance's Anjalee Khemlani reports: Read more here. Mazda forecasts nearly $1 billion profit hit from US tariffs Reuters reports: Read more here. Reuters reports: Read more here. BP vows to do better for investors as profit tops forecast Reuters reports: Read more here. Reuters reports: Read more here. Diageo delivers on annual forecasts, shares jump Reuters reports: Read more here. Reuters reports: Read more here. Dan Ives: Palantir's 'transformational' quarter paves way for $1 trillion market cap Wedbush tech analyst and Palantir (PLTR) bull Dan Ives said he sees the AI software company reaching a trillion-dollar market cap in the next two to three years. "This is transformational, the type of growth they're seeing," Ives said of Palantir's first billion-dollar quarter for revenue, comparing the company to AI-forward Big Tech behemoths like Nvidia (NVDA) and Microsoft (MSFT). "You combine that with what we saw last week from the hyperscalers, that just shows us this AI revolution — it's just started in terms of the next stage of growth," Ives added. Listen to Palantir's earnings call live on the stock page here. Wedbush tech analyst and Palantir (PLTR) bull Dan Ives said he sees the AI software company reaching a trillion-dollar market cap in the next two to three years. "This is transformational, the type of growth they're seeing," Ives said of Palantir's first billion-dollar quarter for revenue, comparing the company to AI-forward Big Tech behemoths like Nvidia (NVDA) and Microsoft (MSFT). "You combine that with what we saw last week from the hyperscalers, that just shows us this AI revolution — it's just started in terms of the next stage of growth," Ives added. Listen to Palantir's earnings call live on the stock page here. Hims & Hers stock tumbles on revenue miss Shares of Hims & Hers (HIMS) slid 11% in after-hours trading following the telehealth company's second quarter results and revenue miss. Earnings came in at $0.17 per share, a slight beat over estimates for $0.16 per share, according to S&P Global Market Intelligence. Second quarter revenue rose 73% year over year, reaching $544.83 million. But it fell short of Wall Street's estimates for $552 million in sales. The company affirmed its full-year guidance of $2.3 billion to $2.4 billion in sales. For the third quarter, it expects $570 million to $590 million in sales. In June, Novo Nordisk (NVO) announced it was terminating an agreement to sell its blockbuster GLP-1 drug Wegovy on the Hims & Hers platform. Investors will be looking to the earnings call for more details on the fallout. Novo Nordisk also cut its sales forecasts for its weight-loss drugs, citing rivals selling compounded versions, such as Hims & Hers. Listen to the earnings call live. Shares of Hims & Hers (HIMS) slid 11% in after-hours trading following the telehealth company's second quarter results and revenue miss. Earnings came in at $0.17 per share, a slight beat over estimates for $0.16 per share, according to S&P Global Market Intelligence. Second quarter revenue rose 73% year over year, reaching $544.83 million. But it fell short of Wall Street's estimates for $552 million in sales. The company affirmed its full-year guidance of $2.3 billion to $2.4 billion in sales. For the third quarter, it expects $570 million to $590 million in sales. In June, Novo Nordisk (NVO) announced it was terminating an agreement to sell its blockbuster GLP-1 drug Wegovy on the Hims & Hers platform. Investors will be looking to the earnings call for more details on the fallout. Novo Nordisk also cut its sales forecasts for its weight-loss drugs, citing rivals selling compounded versions, such as Hims & Hers. Listen to the earnings call live. Palantir stock surges after company reports first billion-dollar quarter Yahoo Finance's Jake Conley reports: Read more here. Yahoo Finance's Jake Conley reports: Read more here. Post-earnings stock moves are more volatile than usual this quarter We're two-thirds of the way through earnings season, and for the most part, the market has floated higher on a flurry of earnings releases. Though some individual reports have led to outsized moves. Yahoo Finance's Josh Schafer writes in today's Morning Brief: Read more here. We're two-thirds of the way through earnings season, and for the most part, the market has floated higher on a flurry of earnings releases. Though some individual reports have led to outsized moves. Yahoo Finance's Josh Schafer writes in today's Morning Brief: Read more here. BioNTech shares rise 4% on better-than-expected earnings US-listed shares of the German drugmaker BioNTech (BNTX) rose about 4% in early trading Monday after the company reported better-than-expected second quarter results as it looks to regain momentum after a post-COVID slump. BioNTech reported a loss of 1.60 euros per share, narrower than the 1.69 euro loss analysts expected, according to data from S&P Global Market Intelligence. Revenue of 260.8 million euros ($301 million) fell short of estimates of 263.68 million euros ($304 million). In June, BioNTech announced it would partner with Bristol Myers Squibb (BMY) on a new cancer treatment. "We aim to establish BNT327 both as a new standard of care across multiple tumor types," BioNTech CEO Ugur Sahin said on the company's earnings call. "We are currently advancing BNT327 across more than 10 indications, including two global registrational trials, with more planned. Our early conviction around this modality and BNT327 has put us in a strong position, and if approved, we aim to be the first or second to launch in a number of indications to patients in need." US-listed shares of the German drugmaker BioNTech (BNTX) rose about 4% in early trading Monday after the company reported better-than-expected second quarter results as it looks to regain momentum after a post-COVID slump. BioNTech reported a loss of 1.60 euros per share, narrower than the 1.69 euro loss analysts expected, according to data from S&P Global Market Intelligence. Revenue of 260.8 million euros ($301 million) fell short of estimates of 263.68 million euros ($304 million). In June, BioNTech announced it would partner with Bristol Myers Squibb (BMY) on a new cancer treatment. "We aim to establish BNT327 both as a new standard of care across multiple tumor types," BioNTech CEO Ugur Sahin said on the company's earnings call. "We are currently advancing BNT327 across more than 10 indications, including two global registrational trials, with more planned. Our early conviction around this modality and BNT327 has put us in a strong position, and if approved, we aim to be the first or second to launch in a number of indications to patients in need." Meatpacker Tyson Foods raises annual revenue forecast on resilient chicken demand Shares of Tyson Foods (TSN) rose 4% in premarket trading on Monday after the company reported fiscal third quarter results and shared that chicken sales are expected to offset beef. Tyson reported adjusted earnings per share of $0.91, and net sales rose 4% to $13.88 billion. Wall Street analysts expected earnings of $0.78 per share on $13.55 billion in revenue. In the third quarter, chicken sales rose 3.5% while volumes increased 2.4%. Volumes in Tyson's beef segment were down 3.1% during the quarter, but sales grew 6.9% as prices jumped 10%. For the fiscal year, Tyson anticipates sales to grow 2% to 3% compared to fiscal 2024 and overall adjusted operating income of $2.1 billion to $2.3 billion. Reuters reports: Read more here. Shares of Tyson Foods (TSN) rose 4% in premarket trading on Monday after the company reported fiscal third quarter results and shared that chicken sales are expected to offset beef. Tyson reported adjusted earnings per share of $0.91, and net sales rose 4% to $13.88 billion. Wall Street analysts expected earnings of $0.78 per share on $13.55 billion in revenue. In the third quarter, chicken sales rose 3.5% while volumes increased 2.4%. Volumes in Tyson's beef segment were down 3.1% during the quarter, but sales grew 6.9% as prices jumped 10%. For the fiscal year, Tyson anticipates sales to grow 2% to 3% compared to fiscal 2024 and overall adjusted operating income of $2.1 billion to $2.3 billion. Reuters reports: Read more here. Wayfair stock soars after furniture retailer swings to a profit Wayfair (W) stock shot up 13% in premarket trading on Monday after the online furniture retailer reported its highest revenue growth and profitability since 2021. Wayfair posted diluted earnings of $0.11 per share, above estimates for a loss of $0.37 per share, according to S&P Global Market Intelligence. Revenue rose 5% to $3.27 billion, beating Wall Street's expectations of $3.12 billion. Net revenue in the US rose 5.3% to $2.9 billion in the quarter, while international net revenue increased 3.1% to $399 million. "The second quarter was a resounding success, defined by accelerating sales and share gain, in tandem with expanding profitability," Wayfair CEO Niraj Shah said in a statement. "As we have discussed over the last few years, we can and will grow profitably, while taking significant share in the market." Wayfair (W) stock shot up 13% in premarket trading on Monday after the online furniture retailer reported its highest revenue growth and profitability since 2021. Wayfair posted diluted earnings of $0.11 per share, above estimates for a loss of $0.37 per share, according to S&P Global Market Intelligence. Revenue rose 5% to $3.27 billion, beating Wall Street's expectations of $3.12 billion. Net revenue in the US rose 5.3% to $2.9 billion in the quarter, while international net revenue increased 3.1% to $399 million. "The second quarter was a resounding success, defined by accelerating sales and share gain, in tandem with expanding profitability," Wayfair CEO Niraj Shah said in a statement. "As we have discussed over the last few years, we can and will grow profitably, while taking significant share in the market." A look at earnings two-thirds of the way through Q2 reporting season The major stock indexes recorded weekly losses on Friday after a full schedule of earnings, new tariff policy for US trading partners, Federal Reserve interest rate decision, and a weaker-than-expected July jobs report. Data from FactSet published Friday showed that we are two-thirds of the way through the second quarter reporting period, with 66% of S&P 500 companies having reported results so far. As of Aug. 1, S&P 500 firms are tracking for 10.3% earnings growth for Q2. If that rate holds, it will mark the third straight quarter of double-digit earnings growth for the index. Investors are still waiting to hear from the remaining third of companies, however. On deck next week are results from AMD (AMD), Snap (SNAP), McDonald's (MCD), Disney (DIS), Uber (UBER), Lyft (LYFT), and more. Here's a look at the earnings calendar for the next five business days: Monday: BioNTech (BNTX), Hims & Hers (HIMS), Palantir (PLTR) Tuesday: AMD (AMD), Amgen (AMGN), BP (BP), Caterpillar (CAT), Duke Energy (DUK), DuPont (DD), Lemonade (LMND), Marathon Petroleum (MPC), Marriott (MAR), Opendoor (OPEN), Pfizer (PFE), Rivian (RIVN), Snap (SNAP), Super Micro Computer (SMCI), Toast (TOST) Wednesday: Airbnb (ABNB), Disney (DIS), DraftKings (DKNG), Dutch Bros (BROS), e.l.f. (ELF), Joby Aviation (JOBY), Lyft (LYFT), McDonald's (MCD), Novavax (NVAX), Occidental Petroleum (OXY), Shopify (SHOP), Sunrun (RUN), Uber (UBER), Zillow Group (Z) Thursday: Atlassian (TEAM), Block (XYZ), Celsius Holdings (CELH), Crocs (CROX), Eli Lilly (LLY), Hertz (HTZ), Instacart (CART), Intuitive Machines (LUNR), Papa John's (PZZA), Peloton (PTON), Pinterest (PINS), Rocket Lab (RKLB), Texas Roadhouse (TXRH), Sweetgreen (SG), Warner Bros. Discovery (WBD), Wynn (WYNN), Yeti (YETI) Friday: Under Armour (UAA), fuboTV (FUBO) The major stock indexes recorded weekly losses on Friday after a full schedule of earnings, new tariff policy for US trading partners, Federal Reserve interest rate decision, and a weaker-than-expected July jobs report. Data from FactSet published Friday showed that we are two-thirds of the way through the second quarter reporting period, with 66% of S&P 500 companies having reported results so far. As of Aug. 1, S&P 500 firms are tracking for 10.3% earnings growth for Q2. If that rate holds, it will mark the third straight quarter of double-digit earnings growth for the index. Investors are still waiting to hear from the remaining third of companies, however. On deck next week are results from AMD (AMD), Snap (SNAP), McDonald's (MCD), Disney (DIS), Uber (UBER), Lyft (LYFT), and more. Here's a look at the earnings calendar for the next five business days: Monday: BioNTech (BNTX), Hims & Hers (HIMS), Palantir (PLTR) Tuesday: AMD (AMD), Amgen (AMGN), BP (BP), Caterpillar (CAT), Duke Energy (DUK), DuPont (DD), Lemonade (LMND), Marathon Petroleum (MPC), Marriott (MAR), Opendoor (OPEN), Pfizer (PFE), Rivian (RIVN), Snap (SNAP), Super Micro Computer (SMCI), Toast (TOST) Wednesday: Airbnb (ABNB), Disney (DIS), DraftKings (DKNG), Dutch Bros (BROS), e.l.f. (ELF), Joby Aviation (JOBY), Lyft (LYFT), McDonald's (MCD), Novavax (NVAX), Occidental Petroleum (OXY), Shopify (SHOP), Sunrun (RUN), Uber (UBER), Zillow Group (Z) Thursday: Atlassian (TEAM), Block (XYZ), Celsius Holdings (CELH), Crocs (CROX), Eli Lilly (LLY), Hertz (HTZ), Instacart (CART), Intuitive Machines (LUNR), Papa John's (PZZA), Peloton (PTON), Pinterest (PINS), Rocket Lab (RKLB), Texas Roadhouse (TXRH), Sweetgreen (SG), Warner Bros. Discovery (WBD), Wynn (WYNN), Yeti (YETI) Friday: Under Armour (UAA), fuboTV (FUBO) Big Tech quarterly results show greater willingness to spend on AI Recent quarterly results from Amazon (AMZN), Alphabet (GOOGL, GOOG), Microsoft (MSFT), and Meta (META) showed Big Tech is still ready to spend hefty sums on artificial intelligence. As the chart below shows, the four tech firms plan to spend $364 billion cumulatively in their fiscal 2025 years. Yahoo Finance's Laura Bratton breaks down Big Tech's AI spending spree: Read more here. Recent quarterly results from Amazon (AMZN), Alphabet (GOOGL, GOOG), Microsoft (MSFT), and Meta (META) showed Big Tech is still ready to spend hefty sums on artificial intelligence. As the chart below shows, the four tech firms plan to spend $364 billion cumulatively in their fiscal 2025 years. Yahoo Finance's Laura Bratton breaks down Big Tech's AI spending spree: Read more here. Colgate-Palmolive beats quarterly estimates on steady demand for essentials Colgate-Palmolive (CL) stock rose on Friday after the Softsoap maker beat first quarter sales and profit estimates. Despite rising prices and tariffs, consumers continued to purchase essential personal care products, the company said. Colgate reported adjusted profit of $0.92 per share, above analysts' estimates of 90 cents per share, according to data compiled by LSEG. Quarterly net sales reached $5.11 billion, beating estimates of $5.03 billion. Reuters reports: Read more here. Colgate-Palmolive (CL) stock rose on Friday after the Softsoap maker beat first quarter sales and profit estimates. Despite rising prices and tariffs, consumers continued to purchase essential personal care products, the company said. Colgate reported adjusted profit of $0.92 per share, above analysts' estimates of 90 cents per share, according to data compiled by LSEG. Quarterly net sales reached $5.11 billion, beating estimates of $5.03 billion. Reuters reports: Read more here. Regeneron beats second-quarter results estimates on Dupixent sales boost Regeneron Pharmaceuticals (REGN) stock rose more than 5% before the bell on Friday after beating Wall Street estimates for its second-quarter revenue and profit. The pharmaceuticals company was helped by robust demand for its blockbuster eczema product, Dupixent. Reuters reports: Read more here. Regeneron Pharmaceuticals (REGN) stock rose more than 5% before the bell on Friday after beating Wall Street estimates for its second-quarter revenue and profit. The pharmaceuticals company was helped by robust demand for its blockbuster eczema product, Dupixent. Reuters reports: Read more here.
